Herpes Simplex Virus Type 1 infection: overview on relevant clinico-pathological features.
about
Topical n -docosanol for management of recurrent herpes labialisLong-term valacyclovir treatment and immune modulation for Herpes-associated erythema multiformeDeciphering Human Cell-Autonomous Anti-HSV-1 Immunity in the Central Nervous SystemImmunological aspects of acute and recurrent herpes simplex keratitisHerpes simplex induced necrotizing tonsillitis in an immunocompromised patient with ulcerative colitisHerpesvirus: an underestimated virus.Silencing herpes simplex virus type 1 capsid protein encoding genes by siRNA: a promising antiviral therapeutic approach.Antiviral natural products and herbal medicines.Herpes simplex virus: isolation, cytopathological characterization and antiviral sensitivity.The combined effects of irradiation and herpes simplex virus type 1 infection on an immortal gingival cell line.Oral complications of cancer and cancer therapy: from cancer treatment to survivorship.Laser treatment of recurrent herpes labialis: a literature review.Corneal lymphangiogenesis in herpetic stromal keratitisCirculating herpes simplex type 1 (HSV-1)-specific CD8+ T cells do not access HSV-1 latently infected trigeminal ganglia.A systematic analysis of host factors reveals a Med23-interferon-λ regulatory axis against herpes simplex virus type 1 replication.Hydrolyzable tannins (chebulagic acid and punicalagin) target viral glycoprotein-glycosaminoglycan interactions to inhibit herpes simplex virus 1 entry and cell-to-cell spread.Effectiveness of topical corticosteroids in addition to antiviral therapy in the management of recurrent herpes labialis: a systematic review and meta-analysisAcute necrotizing herpetic tonsillitis: a report of two cases.Current management and recommendations for access to antiviral therapy of herpes labialisComparing the effect of diode laser against acyclovir cream for the treatment of herpes labialisCan infections cause Alzheimer's disease?Herpes Simplex Virus (HSV) Modulation of Staphylococcus aureus and Candida albicans Initiation of HeLa 299 Cell-Associated BiofilmHSV-1-induced SOCS-1 expression in keratinocytes: use of a SOCS-1 antagonist to block a novel mechanism of viral immune evasionSAMHD1 restricts herpes simplex virus 1 in macrophages by limiting DNA replication.Oral viral infections of adults.Defense against HSV-1 in a murine model is mediated by iNOS and orchestrated by the activation of TLR2 and TLR9 in trigeminal ganglia.Dendritic cells, macrophages, NK and CD8+ T lymphocytes play pivotal roles in controlling HSV-1 in the trigeminal ganglia by producing IL1-beta, iNOS and granzyme B.Strategies for antiviral screening targeting early steps of virus infection.Mass spectrometry-coupled techniques for viral-related disease biomarker identification.Innate antiviral immunity of periodontal tissue.Heparosan-derived heparan sulfate/heparin-like compounds: one kind of potential therapeutic agents.Orofacial viral infections--an update for clinicians.Activity of acetone and methanol extracts from thirty-one medicinal plant species against herpes simplex virus types 1 and 2.Adenovirus-mediated shRNA interference against HSV-1 replication in vitro.Herpes simplex virus (HSV) immediate-early (IE) promoter-directed reporter system for the screening of antiherpetics targeting the early stage of HSV infection.Herpes labialis among dental healthcare providers in Nigeria.Determination of Biofilm Initiation on Virus-infected Cells by Bacteria and Fungi.Rare Occurrence of Herpes Zoster of Trigeminal Nerve following Extraction of Tooth.Anti-herpes simplex virus activity of polysaccharides from Eucheuma gelatinae.Herpes simplex virus 1 infection on a reconstructive free flap.
P2860
Q22306022-AF077E64-586B-490C-990D-0FB115C5973DQ26773170-3A72B225-FD58-4C98-85D1-8AD314904B0CQ26991623-3C6F2991-3629-4244-BDCC-71B7640B2032Q27016103-6CE26DBC-E366-437A-9165-1D6FA844EFC1Q29353626-D9205A5F-1C4B-4C05-BFC9-64BAA334D476Q30241094-51BCBDDF-8F5C-4437-82EA-6DC237F8F4BCQ33560548-40990BFA-81BE-4EE8-BC02-359C99C71845Q33657624-CFBDC8D1-26C7-45D3-AB65-F148B74B0630Q33752368-FC7C8EA6-2641-4806-B770-061DFB902EBCQ33928172-2355AB1A-4448-4474-B375-F140912F5739Q34299445-7FB9D308-F6E3-4FDD-9F5A-489487AB38A2Q34667436-611FC7F8-AA69-4379-B6EC-09E25561C54BQ34674612-5CA04B34-DC9F-4A7B-B7B9-FD37F1ED5069Q34761117-8A5B86D0-143E-4DF4-ABE9-91F723E612A6Q34945388-D62A1BD9-47FC-43F4-A2FE-7A08C831F089Q35076909-E325E6D2-1D83-4903-A252-844B340B2277Q35127801-DF56B953-3EBA-489A-8102-E1834F0F915DQ35243915-6E7B85E9-81D9-428D-9ECD-E721541F647EQ36178308-3A24CE22-5242-4615-8692-4915F2FC1FE0Q36411918-765D3EBA-0A3B-4090-A49A-87AE863DF83DQ36449877-DF3C0F8D-0C0B-42D6-9967-C1623A8C153EQ36789279-C78EFA3E-6EC0-4459-AD1C-573E1BE92E43Q37253362-29320D48-BFA4-465E-B851-C98B86B30C15Q37336418-93AC4F9A-A6D1-4F11-8EDD-645C10F50B83Q37371879-082AAD21-5A30-4404-9C88-A80343512E5AQ37579649-25A93DE3-C269-498B-AF92-249F41867A97Q37658413-68D616A4-604F-475D-AF41-2D5C709FD7ADQ37801587-DE9F555B-13A8-421D-9DEA-0C7FC10F7116Q37816417-2F18D03B-1531-4CB4-9EAB-7BA1D36C603BQ37866356-7737FF93-3917-4CB9-AC69-40E3ACD5966AQ38001955-DC25E319-C414-4003-A60B-BE2F86B1B579Q38246609-114F5B34-B967-4D2D-9311-3EF6A03BEEE1Q39098694-9331B1E7-1918-4051-9559-5E6777B8FE9BQ39449202-6886B67E-5E76-46C0-8AE1-81BB38369B90Q39693154-11B5F2FA-8105-4682-87B7-8029C46CF915Q40138282-AFC13E66-2680-4B43-9F49-7EC5EECA2E82Q40584317-44CB81FB-76C4-4DB1-A7FF-38F7A0778DA0Q40814786-F5B8928C-2FE1-43F7-B13A-B6A7A22DD5E4Q41532519-0D64B39A-0040-4370-8E9E-B45CCEB69016Q41924696-4CC54FB4-EAE7-4FC8-8F97-2009E2BBCE37
P2860
Herpes Simplex Virus Type 1 infection: overview on relevant clinico-pathological features.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Herpes Simplex Virus Type 1 in ...... clinico-pathological features.
@en
Herpes Simplex Virus Type 1 in ...... clinico-pathological features.
@nl
type
label
Herpes Simplex Virus Type 1 in ...... clinico-pathological features.
@en
Herpes Simplex Virus Type 1 in ...... clinico-pathological features.
@nl
prefLabel
Herpes Simplex Virus Type 1 in ...... clinico-pathological features.
@en
Herpes Simplex Virus Type 1 in ...... clinico-pathological features.
@nl
P2860
P1476
Herpes Simplex Virus Type 1 in ...... clinico-pathological features.
@en
P2093
Paolo G Arduino
Stephen R Porter
P2860
P304
P356
10.1111/J.1600-0714.2007.00586.X
P577
2008-02-01T00:00:00Z